← Return to High Risk Myelodysplastic Syndrome: What to Expect?

Discussion
Comment receiving replies
Profile picture for rjperk633 @rjperk633

I do not recall anyone describing her risk factor…her last visit shows diagnosis is MDS- IB2…. Not sure if that helps you to compare..

Mom has thus far not needed any transfusions and her bone biopsy was November 2024.

She has been anemic since March 2023 when she was hospitalized for Covid and Afib. We found this out when I gathered all records before going to see the oncologist.. We were not told to follow up with anyone for the anemia; I believe it was assumed she was anemic from the Covid bout that lasted about two weeks. Someone dropped the ball but we see this as a blessing is disguise…. She didn’t have the mental burden of a diagnosis…

She did bounce back but within a year we were headed to oncology for the eventual diagnosis after the biopsy. She had a two week period of extreme fatigue previous to seeking medical care and eventually oncology.
She was on the sofa a lot; this is very abnormal for Mom.

Her last blood work test was slightly below the previous one 3 months before… and she is having more fatigue but nothing major. She sees oncologist again in October just to recheck blood since she has opted for no treatment. Her fatigue levels will dictate if she needs an appointment sooner…..

Hope this helps you sort thru things….

Jump to this post


Replies to "I do not recall anyone describing her risk factor…her last visit shows diagnosis is MDS- IB2…...."

I think MDS- IB2 is likely intermediate risk which would be same treatment protocol for a MDS high risk.

The way I understand the disease progression is just a certain number to quality as MDS or CML.

As example if Mom is 10% blasts it’s considered MDS.

Also as example if Mom is 12% blasts or 20 %, the disease is called CML ….

I’m not sure the oncologist told us what that number is to differentiate where it’s no longer considered MDS. I will certainly to asking or researching this number.